Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Lina S. Silva-Bermúdez"'
Autor:
Lina S. Silva-Bermúdez, Andrea Vargas-Villanueva, Carlos A. Sánchez-Vallejo, Ana C. Palacio, Andrés F. Buitrago, Carlos O. Mendivil
Publikováno v:
Lipids in Health and Disease, Vol 21, Iss 1, Pp 1-9 (2022)
Abstract Background It is important to identify patients at increased risk of worsening of left ventricular ejection fraction (LVEF) after a myocardial infarction (MI). We aimed to identify the association of various potential biomarkers with LVEF im
Externí odkaz:
https://doaj.org/article/0110be53b4e84a9ab1d7be1716026c3e
Autor:
Mateo Amaya-Montoya, Jairo A. Pinzón-Cortés, Lina S. Silva-Bermúdez, Daniel Ruiz-Manco, Maria C. Pérez-Matos, Mario A. Jiménez-Mora, Carlos O. Mendivil
Publikováno v:
Lipids in Health and Disease, Vol 19, Iss 1, Pp 1-11 (2020)
Abstract Background The functionality of high-density lipoproteins (HDL) is a better cardiovascular risk predictor than HDL concentrations. One of the key elements of HDL functionality is its apolipoprotein composition. Lecithin-cholesterol acyl tran
Externí odkaz:
https://doaj.org/article/2754661916c245378d3d491b505af093
Autor:
Mateo Amaya-Montoya, Jairo A Pinzón-Cortés, Lina S Silva-Bermúdez, Daniel Ruiz-Manco, Maria C Perez-Matos, Mario A Jimenez-Mora, Carlos O Mendivil
Background High-density lipoproteins (HDL) in plasma are strongly and negatively associated with cardiovascular risk, yet interventions to raise HDL have not improved cardiovascular outcomes. HDL functionality and heterogeneity may hold the clue to t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::208f06823e316ea5ed6536f9bb22cafa
https://doi.org/10.21203/rs.2.20333/v2
https://doi.org/10.21203/rs.2.20333/v2
Autor:
Lina S. Silva-Bermudez, Tatyana N. Sevastyanova, Christina Schmuttermaier, Carolina De La Torre, Leonie Schumacher, Harald Klüter, Julia Kzhyshkowska
Publikováno v:
Frontiers in Immunology, Vol 12 (2021)
Macrophages are key innate immune cells that mediate implant acceptance or rejection. Titanium implants degrade over time inside the body, which results in the release of implant wear-off particles. Titanium nanoparticles (TiNPs) favor pro-inflammato
Externí odkaz:
https://doaj.org/article/813da382ea97450aa4341e74d8c13045